133 related articles for article (PubMed ID: 9635827)
1. Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.
Telang NT; Arcuri F; Granata OM; Bradlow HL; Osborne MP; Castagnetta L
Br J Cancer; 1998 May; 77(10):1549-54. PubMed ID: 9635827
[TBL] [Abstract][Full Text] [Related]
2. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells.
Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
Breast Cancer Res Treat; 1993 Sep; 27(3):193-202. PubMed ID: 8312577
[TBL] [Abstract][Full Text] [Related]
3. Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.
Telang NT; Narayanan R; Bradlow HL; Osborne MP
Breast Cancer Res Treat; 1991 Aug; 18(3):155-63. PubMed ID: 1756258
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression.
Telang NT; Osborne MP; Sweterlitsch LA; Narayanan R
Cell Regul; 1990 Oct; 1(11):863-72. PubMed ID: 2088530
[TBL] [Abstract][Full Text] [Related]
5. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
6. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors.
Katdare M; Singhal H; Newmark H; Osborne MP; Telang NT
Cancer Lett; 1997 Jan; 111(1-2):141-7. PubMed ID: 9022139
[TBL] [Abstract][Full Text] [Related]
7. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
8. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.
Telang NT; Suto A; Wong GY; Osborne MP; Bradlow HL
J Natl Cancer Inst; 1992 Apr; 84(8):634-8. PubMed ID: 1556774
[TBL] [Abstract][Full Text] [Related]
9. Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells.
Suto A; Bradlow HL; Wong GY; Osborne MP; Telang NT
Steroids; 1992 Jun; 57(6):262-8. PubMed ID: 1440696
[TBL] [Abstract][Full Text] [Related]
10. Negative growth regulation of oncogene-transformed mammary epithelial cells by tumor inhibitors.
Telang NT; Inoue S; Bradlow HL; Osborne MP
Adv Exp Med Biol; 1997; 400A():409-18. PubMed ID: 9547584
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
Araki R; Inoue S; Osborne MP; Telang NT
Ann N Y Acad Sci; 1995 Sep; 768():215-22. PubMed ID: 8526351
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1.
Sarubbi DJ; Narayanan R; Telang NT; Newman MJ
In Vitro Cell Dev Biol; 1990 Dec; 26(12):1195-201. PubMed ID: 2079465
[TBL] [Abstract][Full Text] [Related]
13. The role of estrogen in mammary carcinogenesis.
Fishman J; Osborne MP; Telang NT
Ann N Y Acad Sci; 1995 Sep; 768():91-100. PubMed ID: 8526389
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
15. Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention.
Telang NT; Kurihara H; Wong GY; Bradlow HL; Osborne MP
Anticancer Res; 1991; 11(3):1021-7. PubMed ID: 1909512
[TBL] [Abstract][Full Text] [Related]
16. In vitro biotransformation of estradiol by explant cultures of murine mammary tissues.
Telang NT; Bradlow HL; Kurihara H; Osborne MP
Breast Cancer Res Treat; 1989 Mar; 13(2):173-81. PubMed ID: 2730963
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
19. Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
Telang NT; Katdare M; Bradlow HL; Osborne MP
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):559-64. PubMed ID: 9167995
[TBL] [Abstract][Full Text] [Related]
20. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.
Kim DW; Sovak MA; Zanieski G; Nonet G; Romieu-Mourez R; Lau AW; Hafer LJ; Yaswen P; Stampfer M; Rogers AE; Russo J; Sonenshein GE
Carcinogenesis; 2000 May; 21(5):871-9. PubMed ID: 10783306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
